CareLit Fachartikel

Kommentar zu „Intravenöse Vitamin C-Gabe: 28-Tage-Ergebnis septischer Patienten verschlechtert?“

N.N. · Aktuelle Ernährungsmedizin · 2022 · Heft 6 · S. 437 bis 439

Dokument
277891
CareLit-ID
Jahr
2022
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Ernährungsmedizin
Autor:innen
N.N.
Ausgabe
Heft 6 / 2022
Jahrgang 47
Seiten
437 bis 439
Erschienen: 2022-12-14 13:00:00
ISSN
0341-0501
DOI
10.1055/a-1923-7798

Zusammenfassung

Rarely the results of a study were expected so eagerly as the LOVIT trial, an acronym for “Lessening Organ Dysfunction with Vitamin C” 1. This blinded multicentric randomised trial (RCT) is a well-performed study 1 testing high-dose intravenous vitamin C (IVVC) (50 mg/kg every 6 h for 96hrs). With 872 patients, the trial is the largest so far. The results are sobering, as the patients receiving IVVC had a worse primary composite outcome compared to the placebo group: of note, the different components of the outcome (death or persistent organ dysfunction), did not differ significantly when considered individually…

Schlagworte

Gesundheit Pflege Vitamin Trial Organ Dysfunction Results Study Patients Outcome Lessening Rarely Expected Eagerly Aktuelle Ernährungsmedizin